EUVIMEDEUVIMED entdecken
Crossref

Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress

Yanhong Han, Chuang Ge, Junmei Ye, Ruiyan Li, Yubin Zhang

Pulmonary Pharmacology & Therapeutics · 2023

DOI: 10.1016/j.pupt.2023.102259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Pharmacology & Therapeutics, 2023. Verfasst von Yanhong Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjin…. Hauptthemen laut MEDLINE: Pulmonary Edema, Pneumonia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute pneumonia induced by Pseudomonas aeruginosa is characterized by massive infiltration of inflammatory cell and the production of reactive oxygen species (ROS), which lead to severe and transient pulmonary inflammation and acute lung injury. However, P.aeruginosa infection is resistant to multiple antibiotics and causes high mortality in clinic, the search for alternative prophylactic and therapeutic strategies is imperative. PURPOSE: This study was aimed to investigate the anti-inflammatory and antioxidant effects of DMB, a novel derivative of berberine, and explore the role of AIM2 inflammasome in P. aeruginosa-induced acute pneumonia. METHODS: Acute pneumonia mice were established by tracheal injection of P. aeruginosa suspension. Pathological changes of lung tissue were observed by its appearance and H&E staining. The lung coefficient ratio was measured to evaluate pulmonary edema. Inflammatory factors were detected by qRT-PCR, western blotting and immunohistochemistry. ROS and other indicators of oxidative damage were analyzed by flow cytometry and specific kit. Proteins related to AIM2 inflammasome were detected by western blotting. RESULTS: Compared with the P. aeruginosa-induced group, DMB ameliorated pulmonary edema, hyperemia, and pathological damage based on its appearance and H&E staining in DMB groups. First, DMB attenuated the inflammatory response induced by P.aeruginosa. Compared with the P. aeruginosa-induced group, the lung coefficient ratio was decreased by 31.5%, the MPO activity of lung tissue was decreased by 44.0%, the mRNA expression levels of TNF-α, IL-1β and IL-6 were decreased by 64.8%, 51.2% and 64.0% respectively, and those protein expression levels were decreased by 40.1%, 42.8% and 47.8% respectively, and the number of white blood cells, neutrophils and monocytes were decreased by 53.5%, 29.4% and 13.7% in high dose (200 mg/kg) DMB group. Second, DMB alleviates oxidative stress in the lung tissue during P. aeruginosa-induced acute pneumonia. Compared with the P. aeruginosa-induced group, the level of GSH was increased by 42.5% and MDA was decreased by 49.5% in high dose DMB group. Moreover, the western blotting results showed that DMB markedly suppressed the expression of AIM2, ASC, Cleaved caspase1 and decreased the secretion of IL-1β. Additionally, these results were also confirmed by in vitro experiments using MH-S and BEAS-2B cell lines. CONCLUSIONS: Taken together, these results indicated that DMB ameliorates P. aeruginosa-induced acute pneumonia through anti-inflammatory, antioxidant effects, and inhibition of AIM2 inflammasome activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EdemaPneumoniaAnimalsMiceInflammasomesPseudomonas aeruginosaReactive Oxygen SpeciesAntioxidantsOxidative StressAnti-Inflammatory AgentsBerberine

Stichwörter der Autor:innen

DemthyleneberberineInflammasomeInflammatory responsesOxidative stressPneumoniaPseudomonas aeruginosa

Substanzen

InflammasomesReactive Oxygen SpeciesAntioxidantsAnti-Inflammatory AgentsdemethyleneberberineBerberine

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
  • State Key Laboratory of Natural Medicines, Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China. Electronic address: ybzhang@cpu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Han, Y., Ge, C., Ye, J., Li, R., & Zhang, Y. (2023). Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress. Pulmonary Pharmacology & Therapeutics. https://doi.org/10.1016/j.pupt.2023.102259

Vancouver

Han Y, Ge C, Ye J, Li R, Zhang Y. Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress. Pulmonary Pharmacology & Therapeutics. 2023. doi:10.1016/j.pupt.2023.102259

BibTeX
@article{Han2023,
  author = {Han, Yanhong and Ge, Chuang and Ye, Junmei and Li, Ruiyan and Zhang, Yubin},
  title = {Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress},
  journal = {Pulmonary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1016/j.pupt.2023.102259}
}
Kostenlos starten →